Tatsuo Kanda

21PUBLICATIONS
45CO-AUTHORS
Major global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsRespiratory diseasesMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 07, 2026
Acute-on-chronic liver failure following pneumonia in an elderly woman with metabolic dysfunction-associated steatotic liver cirrhosis.

|Jun 17, 2026
Antiviral therapy and the risk of extrahepatic malignancies in chronic hepatitis C: insights from recent evidence.

|Jun 15, 2026
Linerixibat reduces cholestatic pruritus in patients with primary biliary cholangitis.

|Mar 28, 2026
Azathioprine Inhibits Hepatitis A Virus Replication In Vitro.

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroyuki Abe

|Feb 17, 2026
Reply to letter to editor "Hepatic irAEs, ICI Continuation, and Survival: Methodological Perspectives and Future Directions".

Tatsuo Kanda, Kaori Matsumoto, Shuntaro Obi

|Feb 12, 2026
STRIDE sustained an overall survival benefit with safety profiles in unresectable hepatocellular carcinoma at 5-year follow-up.

Tatsuo Kanda, Reina Sasaki-Tanaka, Hiroteru Kamimura

Pageof 4

Frequent Collaborators

7 joint publications

Hiroteru Kamimura

6 joint publications

Shuji Terai

6 joint publications

Reina Sasaki-Tanaka

5 joint publications

Kazunao Hayashi